Amoy Diagnostics Co., Ltd. (300685.SZ)
CNY 20.02
(-2.58%)
CNY 20.02
(-2.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 305.64 Million | 149.03 Million | 168.16 Million | 220.69 Million | 151.52 Million | 93.44 Million |
| Net Income | 261.48 Million | 264.29 Million | 239.02 Million | 180.32 Million | 135.47 Million | 126.73 Million |
| Depreciation & Amortization | 59.16 Million | 52.27 Million | 38.9 Million | 27.32 Million | 24.24 Million | 19.71 Million |
| Deferred income taxes | 617.31 Thousand | 13.7 Million | -1.13 Million | -3.66 Million | -5.62 Million | -258.73 Thousand |
| Stock-based compensation | 8.73 Million | 2.22 Million | 15.01 Million | 47.29 Million | 35.38 Million | - |
| Change in working capital | -37.52 Million | -58.9 Million | -125.12 Million | -10.63 Million | -16.99 Million | -49.38 Million |
| Other non-cash items | 177.75 Million | -108.61 Million | 15.35 Million | 23.67 Million | 8.79 Million | -3.62 Million |
| Investing Cash Flow | -338.92 Million | -40.19 Million | -242.67 Million | -325.81 Million | 108 Million | -56.26 Million |
| Investments in PPE | -44.86 Million | -78.28 Million | -74.54 Million | -57.89 Million | -23.31 Million | -38.97 Million |
| Acquisitions | 12.5 Million | 51.93 Million | 8.89 Million | 58 Million | 23.41 Million | 39.18 Million |
| Investment purchases | -899.98 Million | -363.57 Million | -772.14 Million | -1.3 Billion | -30 Million | -734.3 Million |
| Sales/Maturities of investments | 593.41 Million | 350.2 Million | 600.72 Million | 1.03 Billion | 161.21 Million | 716.8 Million |
| Other Investing Activities | -287.12 Million | -483.92 Thousand | -5.59 Million | -57.89 Million | -23.31 Million | -38.97 Million |
| Financing Cash Flow | -18.04 Million | -120.57 Million | -46.31 Million | -17.57 Million | 38.39 Million | -10.1 Million |
| Debt repayment | -2.76 Million | -1.12 Million | -2.4 Million | -49.8 Million | -11.7 Million | -30.9 Million |
| Dividends payments | -55.18 Million | -51.46 Million | -55.28 Million | -36.99 Million | -26.49 Million | -19.8 Million |
| Common Stock Repurchased | -12.03 Million | -100.7 Million | -4.38 Million | -2.82 Million | -340.35 Thousand | - |
| Common Stock Issuance | - | 100.7 Million | - | 2.82 Million | 71.97 Million | - |
| Other Financing Activities | 50.04 Million | -67.98 Million | 13.49 Million | 70.03 Million | 4.99 Million | 40.6 Million |
| Accounts receivables | -10.57 Million | 25.91 Million | -132.31 Million | -80.67 Million | -62.32 Million | -51.75 Million |
| Accounts payables | -31 Million | -97.96 Million | 19.16 Million | 77.97 Million | 54.05 Million | 7 Million |
| Inventory | 4.05 Million | -568.83 Thousand | -10.83 Million | -4.27 Million | -3.09 Million | -4.36 Million |
| Other working capital | -30.38 Million | 13.7 Million | -1.13 Million | -3.66 Million | -5.62 Million | -45.01 Million |
| Cash at beginning of period | 243.97 Million | 230.73 Million | 361.56 Million | 498.39 Million | 198.23 Million | 167.84 Million |
| Cash at end of period | 201.07 Million | 243.59 Million | 230.73 Million | 361.56 Million | 498.39 Million | 198.23 Million |
| Capital Expenditure | -44.86 Million | -78.28 Million | -74.54 Million | -57.89 Million | -23.31 Million | -38.97 Million |
| Effect of forex changes on cash | 8.8 Million | 24.59 Million | -9.99 Million | -14.13 Million | 2.23 Million | 3.31 Million |
| Net cash flow / Change in cash | -42.89 Million | 12.85 Million | -130.82 Million | -136.83 Million | 300.15 Million | 30.39 Million |
| Free Cash Flow | 260.78 Million | 70.75 Million | 93.61 Million | 162.8 Million | 128.21 Million | 54.47 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 83.41 Million | 79.65 Million | 64.19 Million | 87.75 Million | 261.48 Million | 46.97 Million |
| Depreciation & Amortization | - | 15.07 Million | 15.07 Million | 15.22 Million | 59.16 Million | 15.22 Million |
| Deferred income taxes | - | - | - | - | 617.31 Thousand | - |
| Stock-based compensation | - | 14.69 Million | - | 8.73 Million | 8.73 Million | - |
| Change in working capital | - | -39.76 Million | - | -6.51 Million | -37.52 Million | 3.64 Million |
| Other non-cash items | 18.49 Million | -2.41 Million | 21.79 Million | 11.76 Million | 177.75 Million | 26.15 Million |
| Investing Cash Flow | -138.62 Million | 53.59 Million | 45.58 Million | -131.54 Million | -338.92 Million | -98.01 Million |
| Investments in PPE | -8.74 Million | -9.73 Million | -8.31 Million | -8.37 Million | -44.86 Million | -6.69 Million |
| Acquisitions | - | - | - | 12.49 Million | 12.5 Million | - |
| Investment purchases | -165.65 Million | -106.66 Million | -141 Million | -279.09 Million | -899.98 Million | -217.17 Million |
| Sales/Maturities of investments | 35.77 Million | 170 Million | 194.9 Million | 143.41 Million | 593.41 Million | 125.85 Million |
| Other Investing Activities | - | 66.92 Million | 59.31 Million | -122.34 Million | -287.12 Million | - |
| Financing Cash Flow | -60.58 Million | -85.94 Million | -6.26 Million | 55.13 Million | -18.04 Million | -1.33 Million |
| Debt repayment | -620 Thousand | -500 Thousand | -620 Thousand | -6.74 Million | -2.76 Million | -620 Thousand |
| Dividends payments | -12.34 Million | -59.57 Million | -515.81 Thousand | -55.18 Million | -55.18 Million | - |
| Common Stock Repurchased | 41.03 Million | -41.03 Million | - | -12.03 Million | -12.03 Million | 12.03 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -47.61 Million | 16.45 Million | -5.64 Million | 121.48 Million | 50.04 Million | -12.75 Million |
| Accounts receivables | - | -37.59 Million | - | -10.57 Million | -10.57 Million | 2.24 Million |
| Accounts payables | - | - | - | - | -31 Million | - |
| Inventory | - | -2.17 Million | - | 4.05 Million | 4.05 Million | 1.39 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 355.14 Million | 706.46 Million | 201.07 Million | 528.17 Million | 243.97 Million | 227.54 Million |
| Cash at end of period | 252.96 Million | 804.53 Million | 706.46 Million | 201.07 Million | 201.07 Million | 195.34 Million |
| Capital Expenditure | -8.74 Million | -9.73 Million | -8.31 Million | -8.37 Million | -44.86 Million | -6.69 Million |
| Effect of forex changes on cash | -4.11 Million | 1.57 Million | -2.63 Million | -2.14 Million | 8.8 Million | -5.12 Million |
| Net cash flow / Change in cash | -102.18 Million | 98.06 Million | 505.38 Million | -327.1 Million | -42.89 Million | -32.2 Million |
| Free Cash Flow | 93.16 Million | 52.43 Million | 77.67 Million | 75.91 Million | 260.78 Million | 66.42 Million |
XPPLF
LTA
NEOINFRA
BB
SAREGAMA
CVPBF